Close

Explore AI

Explore GPTs

Explore AI News

Explore AI Videos

Explore AI for Jobs

Latest Recursion Pharmaceuticals AI Videos

Find the latest for Recursion Pharmaceuticals company videos

Follow
... 10:2
Palantir’s AI Dominance—Cathie Wood Says It’s Just Getting Started! Hedge Funds Are Piling Into PLTR

YT Finance

1+ months ago 1K views

Paler Technologies stands at the forefront of AI and data analytics, integrating cutting-edge solutions for enterprise and government operations. An exclusive event highlighted real-world case studies showcasing substantial returns on investment for clients. Despite its strong financial performance and recognition, concerns remain about high stock valuations, with analysts questioning the sustainability of its rapid growth. Key investor Kathy Wood from Arc Investment Management continues to express confidence in Paler's long-term potential amidst varying opinions on its current valuation and market strategy as it prepares for significant expansion in 2025.
05:48 - 05:53

Paler anticipates the widespread adoption of AI technology as a strategic advantage.

Palantir Big Data Analytics Finance
... 5:21
PLTR Rallies Off R1 Partnership, Expands A.I. Footprint

Schwab Network

1+ months ago 3K views

Palantir has announced a new partnership with R1 to automate healthcare billing processes through an AI-powered platform called R3. This development aims to streamline payment collection for hospitals and reduce administrative costs, which account for 40% of hospital budgets. In the context of recent partnerships and pressures related to government contracts, Palantir appears to be accelerating its commercial relationships, showcasing impressive growth projections despite ongoing concerns about valuation within the competitive landscape.
Palantir Machine Learning Healthcare
... 13:23
Is Broadcom About to Destroy Nvidia's AI Dominance?

Couch Investor

1+ months ago 6K views

Broadcom's recent quarterly report showed significant earnings growth and guidance improvements, resulting in the stock price rising after hours. The report indicated a market cap nearing $1 trillion, highlighting Broadcom's financial resilience despite a broader market pullback affecting the semiconductor industry, which has seen significant corrections. The focus was placed on robust growth in AI and infrastructure software, with predictions of continued strength in AI semiconductor revenue, marking Broadcom’s positioning against competitors, particularly Nvidia. The CEO discussed strategic partnerships with major tech companies to develop custom silicon for future AI applications.
Broadcom AI hardware Tech & Hardware
... 5:28
Smart Money Is LOADING Tempus AI

Fast Dollar

1+ months ago 1K views

Tempest AI has recently seen significant institutional buying despite a dip in its stock prices stemming from executive sell-offs. Major players like Kathy Wood, GP Morgan, and UBS are accumulating shares, indicating confidence in the company’s potential amidst broader market declines for tech stocks. The unique attributes of Tempest AI include its substantial involvement in AI applications in healthcare, such as diagnostics and drug discovery. While retail investors may panic, institutions appear to recognize a long-term opportunity, underscoring the importance of AI in future medicinal advancements.
Tempus AI Finance
... 12:34
Top AI Growth Stock To Watch now - March 2025 - AI stock - Gorilla Technology GRRR stock $PLTR $NVDA

Paul Thomas Investing

1+ months ago 4K views

Gorilla Technologies' stock experienced significant volatility, dropping 30% before rallying back 50%. The company, which specializes in AI-driven security and IoT solutions, has shown remarkable growth, gaining around 400% in recent months. Their innovative technologies, including AI-powered facial recognition and surveillance, position them favorably within the market. Despite a low price-to-earnings ratio and a strong patent portfolio, challenges persist with transparency in financial reporting and workforce reductions. Upcoming agreements, such as the collaboration for the 'internet of forests,' indicate promising future prospects.
07:09 - 07:35

Gorilla signed a deal for the world's first Internet of Forests, enhancing environmental monitoring.

Gorilla Technology Machine Learning Finance
... 8:29
IPA Stock - AI Company to Watch (Update)

Blaze Capital

1+ months ago 10K views

Immuno Precise Antibodies (IPA), listed on NASDAQ as IPA, aims to revolutionize healthcare and drug discovery through its patented Lens AI technology. With over 90% of clinical drug developments failing, IPA addresses this challenge by accelerating drug discovery and integrating artificial intelligence with biological data. Their HFT patterns program introduces unique signature sequences, enabling the harmonization of complex biological data. The potential market for AI in drug discovery is projected to be worth $24.6 billion by 2029. The company is making strides in developing precision-targeted treatments, particularly for cancer, enhancing drug efficacy with fewer side effects.
04:01 - 04:06

In silico antibodies targeting tumor proteins show AI's efficacy in drug development.

Immunoprecise Antibodies Ltd Finance
... 8:55
Reploy AI Review: Why This Could Be The Crypto AI Winner In 2025

KIFS Crypto

1+ months ago 3K views

Repo AI presents an innovative platform that combines advanced artificial intelligence to optimize digital workflows. The platform assists businesses and developers in quickly deploying AI solutions, enhancing productivity through automation, process optimization, and intelligent applications. Key offerings include an AI-powered visual development platform, an automated trading agent, and a cloud-based platform for managing smart contracts. The tokenomics of Repo AI involve strategic allocation and a subscription-based revenue model to incentivize growth and community engagement. The video further discusses the current market performance of Repo AI tokens and anticipates upcoming product launches.
05:15 - 05:31

The all-time high was $1363, indicating significant market volatility and potential.

Reploy AI Blockchain Finance
... 34:12
Tempus A.I. Stock (TEM) is Crazy! | Deep Analysis on TEM Stock

H Invests

1+ months ago 2K views

Tempus AI focuses on leveraging artificial intelligence to enhance healthcare diagnostics, particularly in oncology. Founded in 2015, it has been using AI and machine learning to analyze laboratory test results in context with patient histories. The CEO discusses how the company aims to improve patient outcomes through personalized treatment plans by utilizing extensive genomic data while also expanding its services to cover various diseases beyond cancer. Despite operating at a loss, Tempus AI is experiencing rapid growth and plans to achieve profitability by 2025, driving significant potential in the healthcare market.
11:24 - 12:02

Tempus AI has a unique position with a database 20 times larger for cancer genomics.

Tempus Machine Learning Finance
... 34:12
Tempus A.I. Stock (TEM) is Crazy! | Deep Analysis on TEM Stock

H Invests

1+ months ago 2K views

Tempus AI focuses on leveraging artificial intelligence to enhance healthcare diagnostics, particularly in oncology. Founded in 2015, it has been using AI and machine learning to analyze laboratory test results in context with patient histories. The CEO discusses how the company aims to improve patient outcomes through personalized treatment plans by utilizing extensive genomic data while also expanding its services to cover various diseases beyond cancer. Despite operating at a loss, Tempus AI is experiencing rapid growth and plans to achieve profitability by 2025, driving significant potential in the healthcare market.
11:24 - 12:02

Tempus AI has a unique position with a database 20 times larger for cancer genomics.

Tempus Machine Learning Finance